This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Sanofi. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Sharon Aurore Wein: Innovator in Antimalarial Treatments
Introduction
Sharon Aurore Wein is a prominent inventor based in Paris, France. She has made significant contributions to the field of medicine, particularly in the development of antimalarial treatments. Her innovative work has led to the creation of a unique pharmaceutical composition aimed at combating malaria.
Latest Patents
Sharon Aurore Wein holds a patent for a combination of a bis-thiazolium salt or a precursor thereof and artemisinin or a derivative thereof for treating acute malaria. This invention relates to a combination of antimalarial active ingredients, specifically designed to enhance the effectiveness of malaria treatment. The patent also covers a pharmaceutical composition comprising this combination and its use in the treatment and/or prevention of malaria. She has 1 patent to her name.
Career Highlights
Throughout her career, Sharon has worked with notable organizations, including Sanofi and the University of Montpellier II. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Sharon has collaborated with esteemed colleagues such as Laurent Fraisse and Henri Vial. These partnerships have played a crucial role in advancing her research and the development of her innovative solutions.
Conclusion
Sharon Aurore Wein's contributions to antimalarial treatments highlight her dedication to improving global health. Her innovative patent and collaborations with leading organizations underscore her impact in the field of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
